Great West Life Assurance Co. Can Has $55.11 Million Position in CIGNA Co. (CI)

Great West Life Assurance Co. Can decreased its position in CIGNA Co. (NYSE:CI) by 15.9% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 328,293 shares of the health services provider’s stock after selling 62,128 shares during the quarter. Great West Life Assurance Co. Can owned 0.13% of CIGNA worth $55,107,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the stock. Commerzbank Aktiengesellschaft FI raised its holdings in CIGNA by 19.5% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 1,667 shares of the health services provider’s stock valued at $339,000 after acquiring an additional 272 shares in the last quarter. HPM Partners LLC raised its holdings in CIGNA by 8.1% in the fourth quarter. HPM Partners LLC now owns 4,256 shares of the health services provider’s stock valued at $864,000 after acquiring an additional 319 shares in the last quarter. Crossmark Global Holdings Inc. raised its holdings in CIGNA by 1.3% in the fourth quarter. Crossmark Global Holdings Inc. now owns 29,786 shares of the health services provider’s stock valued at $6,049,000 after acquiring an additional 379 shares in the last quarter. Brown Advisory Inc. raised its holdings in CIGNA by 1.7% in the fourth quarter. Brown Advisory Inc. now owns 23,562 shares of the health services provider’s stock valued at $4,785,000 after acquiring an additional 399 shares in the last quarter. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in CIGNA by 22.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 2,262 shares of the health services provider’s stock valued at $459,000 after acquiring an additional 408 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Shares of CIGNA opened at $175.90 on Monday, according to MarketBeat.com. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.35 and a current ratio of 0.35. The company has a market cap of $42.79 billion, a PE ratio of 16.82, a price-to-earnings-growth ratio of 1.08 and a beta of 0.59. CIGNA Co. has a 12-month low of $159.91 and a 12-month high of $227.13.

CIGNA (NYSE:CI) last announced its earnings results on Thursday, May 3rd. The health services provider reported $4.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.39 by $0.72. The business had revenue of $11.38 billion for the quarter, compared to analyst estimates of $10.97 billion. CIGNA had a net margin of 5.99% and a return on equity of 20.90%. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period last year, the firm posted $2.77 earnings per share. analysts anticipate that CIGNA Co. will post 13.23 earnings per share for the current year.

Several analysts recently weighed in on the stock. Credit Suisse Group raised their target price on shares of CIGNA from $215.00 to $218.00 and gave the company an “outperform” rating in a report on Friday, May 4th. Zacks Investment Research raised shares of CIGNA from a “sell” rating to a “hold” rating in a report on Monday, April 16th. Sanford C. Bernstein assumed coverage on shares of CIGNA in a report on Tuesday, March 13th. They set a “market perform” rating and a $194.00 price objective on the stock. Barclays assumed coverage on shares of CIGNA in a report on Thursday, March 8th. They set an “overweight” rating and a $235.00 price objective on the stock. Finally, Oppenheimer raised their price objective on shares of CIGNA to $237.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Five investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $212.50.

In other news, EVP Nicole S. Jones sold 5,856 shares of the firm’s stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $190.68, for a total transaction of $1,116,622.08. Following the transaction, the executive vice president now directly owns 36,658 shares in the company, valued at $6,989,947.44. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO David Cordani sold 36,769 shares of the firm’s stock in a transaction that occurred on Monday, March 5th. The stock was sold at an average price of $191.68, for a total transaction of $7,047,881.92. Following the transaction, the chief executive officer now owns 372,076 shares in the company, valued at $71,319,527.68. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 45,384 shares of company stock worth $8,693,791. Insiders own 1.10% of the company’s stock.

About CIGNA

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.

Institutional Ownership by Quarter for CIGNA (NYSE:CI)

Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply